Frank Pétavy
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 3
-
- Statistical Methods in Clinical Trials 8
- Advanced Causal Inference Techniques 7
- Co-authors
- Iman El‐Hariry (2 shared papers)Guido Rasi (4 shared papers)Philippe Beuzeboc (1 shared paper)D. J. Richel (1 shared paper)Uwe Treiber (1 shared paper)Jean‐Pascal Machiels (1 shared paper)Christian Wülfing (1 shared paper)Marco R. de Groot (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (4 papers)Trials (2 papers)Nephrology Dialysis Transplantation (2 papers)Nature Reviews Drug Discovery (2 papers)Statistics in Biopharmaceutical Research (2 papers)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Frank Pétavy
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 119
- Nephrology 118
- Statistics and Probability 128
- Health Informatics 17
- Oncology 162
- Pulmonary and Respiratory Medicine 152
Countries citing papers authored by Frank Pétavy
This map shows the geographic impact of Frank Pétavy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Pétavy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Pétavy more than expected).
Fields of papers citing papers by Frank Pétavy
This network shows the impact of papers produced by Frank Pétavy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Pétavy. The network helps show where Frank Pétavy may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Pétavy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 172 | |
| 2 | 2020 | 103 | |
| 3 | 2008 | 78 | |
| 4 | 2010 | 75 | |
| 5 | 2020 | 59 | |
| 6 | 2016 | 55 | |
| 7 | 2012 | 50 | |
| 8 | 2020 | 48 | |
| 9 | 2019 | 44 | |
| 10 | 2005 | 41 | |
| 11 | 2013 | 40 | |
| 12 | 2016 | 36 | |
| 13 | 2021 | 35 | |
| 14 | Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis. | 2012 | 26 |
| 15 | 2018 | 26 | |
| 16 | 2010 | 25 | |
| 17 | 2022 | 21 | |
| 18 | 2010 | 20 | |
| 19 | 2020 | 18 | |
| 20 | Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study. | 2013 | 18 |
About Frank Pétavy
Frank Pétavy is a scholar working on Economics and Econometrics, Statistics and Probability, Nephrology, Molecular Biology and General Health Professions, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Statistical Methods in Clinical Trials (8 papers), Advanced Causal Inference Techniques (7 papers), Parathyroid Disorders and Treatments (5 papers), Pharmaceutical Economics and Policy (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Ethics in Clinical Research (2 papers). The work is most often cited by research in Nephrology (118 citations), Statistics and Probability (128 citations), Health Informatics (17 citations), Oncology (162 citations) and Pulmonary and Respiratory Medicine (152 citations). Frank Pétavy has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Iman El‐Hariry, Guido Rasi, Philippe Beuzeboc, D. J. Richel, Uwe Treiber, Jean‐Pascal Machiels, Christian Wülfing, Marco R. de Groot, Roma Parikh and Marc‐Oliver Grimm. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Trials, Nephrology Dialysis Transplantation, Nature Reviews Drug Discovery and Statistics in Biopharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.